Primary |
Factor Viii Deficiency |
64.9% |
Haemophilia |
7.6% |
Prophylaxis |
4.9% |
Haemorrhage |
2.7% |
Pain |
2.7% |
Haemorrhage Prophylaxis |
2.0% |
Knee Arthroplasty |
2.0% |
Viral Infection |
2.0% |
Constipation |
1.3% |
Hypertension |
1.1% |
Off Label Use |
1.1% |
Post Procedural Haemorrhage |
1.1% |
Anti Factor Viii Antibody Positive |
0.9% |
Central Venous Catheterisation |
0.9% |
Cerebral Haemorrhage |
0.9% |
Migraine |
0.9% |
Surgery |
0.9% |
Candidiasis |
0.7% |
Convulsion |
0.7% |
Traumatic Haemorrhage |
0.7% |
|
Factor Viii Inhibition |
39.7% |
Haemarthrosis |
10.3% |
Haemorrhage |
7.8% |
Drug Ineffective |
6.6% |
Muscle Haemorrhage |
4.9% |
Anti Factor Viii Antibody Positive |
4.6% |
Pain In Extremity |
4.3% |
Haematoma |
3.4% |
Therapy Non-responder |
3.2% |
No Therapeutic Response |
2.3% |
Spontaneous Haematoma |
2.3% |
Infection |
1.7% |
Drug Specific Antibody Present |
1.1% |
Ecchymosis |
1.1% |
Free Haemoglobin Present |
1.1% |
Hypersensitivity |
1.1% |
Incorrect Product Storage |
1.1% |
Post Procedural Haemorrhage |
1.1% |
Weight Increased |
1.1% |
Central Venous Catheter Removal |
0.9% |
|
Secondary |
Factor Viii Deficiency |
60.3% |
Haemorrhage Prophylaxis |
6.1% |
Pain |
4.8% |
Prophylaxis |
4.2% |
Anti Factor Viii Antibody Positive |
3.2% |
Bronchitis Chronic |
2.9% |
Constipation |
2.3% |
Haemophilia |
1.9% |
Central Venous Catheterisation |
1.4% |
Cerebral Haemorrhage |
1.4% |
Hypertension |
1.4% |
Knee Arthroplasty |
1.4% |
Migraine |
1.4% |
Haemorrhage |
1.3% |
Candidiasis |
1.1% |
Convulsion |
1.1% |
Hiv Infection |
1.0% |
Viral Infection |
1.0% |
Arthralgia |
0.8% |
Arthritis |
0.8% |
|
Factor Viii Inhibition |
36.0% |
Pain In Extremity |
10.0% |
Free Haemoglobin Present |
6.6% |
Haemorrhage |
6.2% |
Drug Ineffective |
5.2% |
Haemarthrosis |
4.5% |
Spontaneous Haematoma |
4.5% |
Haematoma |
4.3% |
Anti Factor Viii Antibody Positive |
3.6% |
Ecchymosis |
3.1% |
Post Procedural Haemorrhage |
3.1% |
Drug Specific Antibody Present |
2.8% |
Traumatic Brain Injury |
2.1% |
Infection |
1.4% |
Muscle Haemorrhage |
1.4% |
No Therapeutic Response |
1.2% |
Synovitis |
1.2% |
Hypersensitivity |
0.9% |
Oesophageal Varices Haemorrhage |
0.9% |
Pleurisy |
0.9% |
|
Concomitant |
Hepatitis C |
35.3% |
Chronic Hepatitis C |
17.6% |
Haemophilia |
17.6% |
Hypertension |
17.6% |
Prophylaxis |
11.8% |
|
Photosensitivity Reaction |
60.0% |
Haemarthrosis |
40.0% |
|